NASDAQ·Biological Products, (No Diagnostic Substances)
SCNI
Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. (ticker: SCNI) is an NASDAQ-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of SCNI's SEC filings surfaces 6 active risk signals, including 4 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. SCNI reported $1.31M in revenue and -$8.31M for the period ending 2025-12-31, with operating cash flow of -$6.03M. Cash and equivalents stood at $1.66M (down 15.4% year-over-year). Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
SCNI SEC Filings
Full cached SEC EDGAR filing history for SCNI, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.